Understanding the impact of pathophysiological alterations during critical illness on drug pharmacokinetics.

Jamal, Janattul-Ain; Roger, Claire; Roberts, Jason A

Jamal, Janattul-Ain; Roger, Claire; Roberts, Jason A.

Afiliação

Jamal JA; Department of Pharmacy, Hospital Tengku Ampuan Afzan, 25100 Kuantan, Pahang, Malaysia.
Roger C; Department of Anaesthesiology, Emergency and Critical Care Medicine, Intensive Care Unit, Nîmes University Hospital, place du Professeur Debré, 30029 Nîmes, France.
Roberts JA; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia; Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia. Electronic address: j.roberts2@uq.edu.au.

Anaesth Crit Care Pain Med ; 37(6): 515-517, 2018 12.

Article em En | MEDLINE | ID: mdl-30359771

Assuntos

Queimaduras; Estado Terminal; Humanos; Sevoflurano

Palavras-chave

Critical illness; Drug dosing; Pathophysiologic; Pharmacokinetic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Queimaduras / Estado Terminal Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google